Browsing by Author Nowak, Anna K.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2007Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.Beale, Philip; Carter, Candace; Dhillon, Haryana; Heritier, Stephane; Hickie, Ian; O'Connell, Rachel; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Abdi, Ehtesham A; Glasgow, Amanda; Goldstein, David; Jefford, Michael; Nowak, Anna K.; Turner, Jane; Wyld, David; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Brain & Mind Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial., Lancet Oncology, vol.8,(7),2007,pp 603-612
2016Evolving management of low grade glioma: No consensus amongst treating cliniciansKhasraw, Mustafa; Sawkins, Kate; Field, K.M.; Nowak, Anna K.; Rosenthal, M.A.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEvolving management of low grade glioma: No consensus amongst treating clinicians, Journal of Clinical Neuroscience, vol.23, N/A, 2016,pp 81-87
2017Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastomaBarnes, Elizabeth; Espinoza, David; King, Madeleine; Sawkins, Kate; Simes, Robert John; Cher, L; Field, Kathryn; Hovey, Elizabeth; Nowak, Anna K.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma, Journal of Neuro-Oncology, vol.133, N/A, 2017,pp 623-631
2011Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?Blinman, Prunella; Brown, Christopher; Duric, Vlatka; Stockler, Martin; Fong, K; McLachlan, Sue-Anne; Millward, Michael; Nowak, Anna K.; Wright, Gavin; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?, Lung cancer, vol.72, 2, 2011,pp 213-218
2013The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' EstimatesBeale, Philip; Kiely, Belinda Emma; Martin, Andrew; Stockler, Martin; Tattersall, Martin; Wilcken, Nicholas; Abdi, Ehtesham A; Glare, Paul A.; Glasgow, Amanda; Goldstein, David; Jefford, Michael; Nowak, Anna K.; Wyld, David; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates, Journal of Clinical Oncology, vol.31, 28, 2013,pp 3565-3571
2011Novel Targeted Therapies and Vaccination Strategies for MesotheliomaBagia, Mamta; Nowak, Anna K.; School of Public Health: NH&MRC Clinical Trials CentreNovel Targeted Therapies and Vaccination Strategies for Mesothelioma, Current Treatment Options in Oncology, vol.12, 2, 2011,pp 149-162
2011Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapyBrown, Christopher; Rosenthal, Mark; Simes, Robert John; Ananda, Sumitra; Cher, Lawrence; Dowling, Anthony; Nowak, Anna K.; Medicine Faculty Office; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentrePhase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy, Journal of Clinical Neuroscience, vol.18, 11, 2011,pp 1444-1448
2017The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Barnes, Elizabeth; Sawkins, Kate; Simes, Robert John; Cher, Lawrence; Field, Kathryn; Fitt, G; Goh, Christine; Hovey, Elizabeth; Nowak, Anna K.; Phal, Pramit M.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreThe role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET), Cancer, vol.123, 18, 2017,pp 3576-3582